Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biological Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Cancer Growth Blockers
1.2.5 Blood Cell Growth Factors
1.3 Market by Application
1.3.1 Global Cancer Biological Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research & Academic Laboratories
1.3.5 Pharmaceutical & Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biological Therapy Market Perspective (2018-2033)
2.2 Global Cancer Biological Therapy Growth Trends by Region
2.2.1 Cancer Biological Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Biological Therapy Historic Market Size by Region (2018-2023)
2.2.3 Cancer Biological Therapy Forecasted Market Size by Region (2024-2033)
2.3 Cancer Biological Therapy Market Dynamics
2.3.1 Cancer Biological Therapy Industry Trends
2.3.2 Cancer Biological Therapy Market Drivers
2.3.3 Cancer Biological Therapy Market Challenges
2.3.4 Cancer Biological Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Biological Therapy by Players
3.1.1 Global Cancer Biological Therapy Revenue by Players (2018-2023)
3.1.2 Global Cancer Biological Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Biological Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cancer Biological Therapy Market Concentration Ratio
3.4.1 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Therapy Revenue in 2022
3.5 Global Key Players of Cancer Biological Therapy Head office and Area Served
3.6 Global Key Players of Cancer Biological Therapy, Product and Application
3.7 Global Key Players of Cancer Biological Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biological Therapy Breakdown Data by Type
4.1 Global Cancer Biological Therapy Historic Market Size by Type (2018-2023)
4.2 Global Cancer Biological Therapy Forecasted Market Size by Type (2024-2033)
5 Cancer Biological Therapy Breakdown Data by Application
5.1 Global Cancer Biological Therapy Historic Market Size by Application (2018-2023)
5.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Biological Therapy Market Size (2018-2033)
6.2 North America Cancer Biological Therapy Market Size by Type
6.2.1 North America Cancer Biological Therapy Market Size by Type (2018-2023)
6.2.2 North America Cancer Biological Therapy Market Size by Type (2024-2033)
6.2.3 North America Cancer Biological Therapy Market Share by Type (2018-2033)
6.3 North America Cancer Biological Therapy Market Size by Application
6.3.1 North America Cancer Biological Therapy Market Size by Application (2018-2023)
6.3.2 North America Cancer Biological Therapy Market Size by Application (2024-2033)
6.3.3 North America Cancer Biological Therapy Market Share by Application (2018-2033)
6.4 North America Cancer Biological Therapy Market Size by Country
6.4.1 North America Cancer Biological Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cancer Biological Therapy Market Size by Country (2018-2023)
6.4.3 North America Cancer Biological Therapy Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer Biological Therapy Market Size (2018-2033)
7.2 Europe Cancer Biological Therapy Market Size by Type
7.2.1 Europe Cancer Biological Therapy Market Size by Type (2018-2023)
7.2.2 Europe Cancer Biological Therapy Market Size by Type (2024-2033)
7.2.3 Europe Cancer Biological Therapy Market Share by Type (2018-2033)
7.3 Europe Cancer Biological Therapy Market Size by Application
7.3.1 Europe Cancer Biological Therapy Market Size by Application (2018-2023)
7.3.2 Europe Cancer Biological Therapy Market Size by Application (2024-2033)
7.3.3 Europe Cancer Biological Therapy Market Share by Application (2018-2033)
7.4 Europe Cancer Biological Therapy Market Size by Country
7.4.1 Europe Cancer Biological Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cancer Biological Therapy Market Size by Country (2018-2023)
7.4.3 Europe Cancer Biological Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Biological Therapy Market Size (2018-2033)
8.2 China Cancer Biological Therapy Market Size by Type
8.2.1 China Cancer Biological Therapy Market Size by Type (2018-2023)
8.2.2 China Cancer Biological Therapy Market Size by Type (2024-2033)
8.2.3 China Cancer Biological Therapy Market Share by Type (2018-2033)
8.3 China Cancer Biological Therapy Market Size by Application
8.3.1 China Cancer Biological Therapy Market Size by Application (2018-2023)
8.3.2 China Cancer Biological Therapy Market Size by Application (2024-2033)
8.3.3 China Cancer Biological Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cancer Biological Therapy Market Size (2018-2033)
9.2 Asia Cancer Biological Therapy Market Size by Type
9.2.1 Asia Cancer Biological Therapy Market Size by Type (2018-2023)
9.2.2 Asia Cancer Biological Therapy Market Size by Type (2024-2033)
9.2.3 Asia Cancer Biological Therapy Market Share by Type (2018-2033)
9.3 Asia Cancer Biological Therapy Market Size by Application
9.3.1 Asia Cancer Biological Therapy Market Size by Application (2018-2023)
9.3.2 Asia Cancer Biological Therapy Market Size by Application (2024-2033)
9.3.3 Asia Cancer Biological Therapy Market Share by Application (2018-2033)
9.4 Asia Cancer Biological Therapy Market Size by Region
9.4.1 Asia Cancer Biological Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cancer Biological Therapy Market Size by Region (2018-2023)
9.4.3 Asia Cancer Biological Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cancer Biological Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cancer Biological Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ELI Lilly
11.1.1 ELI Lilly Company Details
11.1.2 ELI Lilly Business Overview
11.1.3 ELI Lilly Cancer Biological Therapy Introduction
11.1.4 ELI Lilly Revenue in Cancer Biological Therapy Business (2018-2023)
11.1.5 ELI Lilly Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Cancer Biological Therapy Introduction
11.2.4 Sanofi Revenue in Cancer Biological Therapy Business (2018-2023)
11.2.5 Sanofi Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Cancer Biological Therapy Introduction
11.3.4 Merck Revenue in Cancer Biological Therapy Business (2018-2023)
11.3.5 Merck Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Cancer Biological Therapy Introduction
11.4.4 Bayer Revenue in Cancer Biological Therapy Business (2018-2023)
11.4.5 Bayer Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cancer Biological Therapy Introduction
11.5.4 Roche Revenue in Cancer Biological Therapy Business (2018-2023)
11.5.5 Roche Recent Developments
11.6 Novartis International
11.6.1 Novartis International Company Details
11.6.2 Novartis International Business Overview
11.6.3 Novartis International Cancer Biological Therapy Introduction
11.6.4 Novartis International Revenue in Cancer Biological Therapy Business (2018-2023)
11.6.5 Novartis International Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Cancer Biological Therapy Introduction
11.7.4 Pfizer Revenue in Cancer Biological Therapy Business (2018-2023)
11.7.5 Pfizer Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Cancer Biological Therapy Introduction
11.8.4 Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2018-2023)
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics Cancer Biological Therapy Introduction
11.9.4 Seattle Genetics Revenue in Cancer Biological Therapy Business (2018-2023)
11.9.5 Seattle Genetics Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Cancer Biological Therapy Introduction
11.10.4 Amgen Revenue in Cancer Biological Therapy Business (2018-2023)
11.10.5 Amgen Recent Developments
11.11 Takeda Pharmaceuticals
11.11.1 Takeda Pharmaceuticals Company Details
11.11.2 Takeda Pharmaceuticals Business Overview
11.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Introduction
11.11.4 Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2018-2023)
11.11.5 Takeda Pharmaceuticals Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Cancer Biological Therapy Introduction
11.12.4 GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2018-2023)
11.12.5 GlaxoSmithKline Recent Developments
11.13 Spectrum Pharmaceuticals
11.13.1 Spectrum Pharmaceuticals Company Details
11.13.2 Spectrum Pharmaceuticals Business Overview
11.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Introduction
11.13.4 Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2018-2023)
11.13.5 Spectrum Pharmaceuticals Recent Developments
11.14 Celgene Corporation
11.14.1 Celgene Corporation Company Details
11.14.2 Celgene Corporation Business Overview
11.14.3 Celgene Corporation Cancer Biological Therapy Introduction
11.14.4 Celgene Corporation Revenue in Cancer Biological Therapy Business (2018-2023)
11.14.5 Celgene Corporation Recent Developments
11.15 AstraZeneca, Plc.
11.15.1 AstraZeneca, Plc. Company Details
11.15.2 AstraZeneca, Plc. Business Overview
11.15.3 AstraZeneca, Plc. Cancer Biological Therapy Introduction
11.15.4 AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2018-2023)
11.15.5 AstraZeneca, Plc. Recent Developments
11.16 Otsuka
11.16.1 Otsuka Company Details
11.16.2 Otsuka Business Overview
11.16.3 Otsuka Cancer Biological Therapy Introduction
11.16.4 Otsuka Revenue in Cancer Biological Therapy Business (2018-2023)
11.16.5 Otsuka Recent Developments
11.17 Eisai
11.17.1 Eisai Company Details
11.17.2 Eisai Business Overview
11.17.3 Eisai Cancer Biological Therapy Introduction
11.17.4 Eisai Revenue in Cancer Biological Therapy Business (2018-2023)
11.17.5 Eisai Recent Developments
11.18 Abbvie
11.18.1 Abbvie Company Details
11.18.2 Abbvie Business Overview
11.18.3 Abbvie Cancer Biological Therapy Introduction
11.18.4 Abbvie Revenue in Cancer Biological Therapy Business (2018-2023)
11.18.5 Abbvie Recent Developments
11.19 Incyte
11.19.1 Incyte Company Details
11.19.2 Incyte Business Overview
11.19.3 Incyte Cancer Biological Therapy Introduction
11.19.4 Incyte Revenue in Cancer Biological Therapy Business (2018-2023)
11.19.5 Incyte Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Biological Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Vaccines
Table 4. Key Players of Cancer Growth Blockers
Table 5. Key Players of Blood Cell Growth Factors
Table 6. Global Cancer Biological Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Cancer Biological Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cancer Biological Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Biological Therapy Market Share by Region (2018-2023)
Table 10. Global Cancer Biological Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Cancer Biological Therapy Market Share by Region (2024-2033)
Table 12. Cancer Biological Therapy Market Trends
Table 13. Cancer Biological Therapy Market Drivers
Table 14. Cancer Biological Therapy Market Challenges
Table 15. Cancer Biological Therapy Market Restraints
Table 16. Global Cancer Biological Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Biological Therapy Revenue Share by Players (2018-2023)
Table 18. Global Top Cancer Biological Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2022)
Table 19. Global Cancer Biological Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Cancer Biological Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Cancer Biological Therapy, Headquarters and Area Served
Table 22. Global Key Players of Cancer Biological Therapy, Product and Application
Table 23. Global Key Players of Cancer Biological Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Biological Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Biological Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Biological Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Cancer Biological Therapy Revenue Market Share by Type (2024-2033)
Table 29. Global Cancer Biological Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Biological Therapy Revenue Share by Application (2018-2023)
Table 31. Global Cancer Biological Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Cancer Biological Therapy Revenue Share by Application (2024-2033)
Table 33. North America Cancer Biological Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Cancer Biological Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Cancer Biological Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Cancer Biological Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Cancer Biological Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Cancer Biological Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Cancer Biological Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Cancer Biological Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Cancer Biological Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Cancer Biological Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Cancer Biological Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Cancer Biological Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Cancer Biological Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Cancer Biological Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Cancer Biological Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Cancer Biological Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Cancer Biological Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Cancer Biological Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Cancer Biological Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Cancer Biological Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Cancer Biological Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Cancer Biological Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Cancer Biological Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Cancer Biological Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Cancer Biological Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cancer Biological Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 65. ELI Lilly Company Details
Table 66. ELI Lilly Business Overview
Table 67. ELI Lilly Cancer Biological Therapy Product
Table 68. ELI Lilly Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 69. ELI Lilly Recent Developments
Table 70. Sanofi Company Details
Table 71. Sanofi Business Overview
Table 72. Sanofi Cancer Biological Therapy Product
Table 73. Sanofi Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 74. Sanofi Recent Developments
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Cancer Biological Therapy Product
Table 78. Merck Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 79. Merck Recent Developments
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Cancer Biological Therapy Product
Table 83. Bayer Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 84. Bayer Recent Developments
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Cancer Biological Therapy Product
Table 88. Roche Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 89. Roche Recent Developments
Table 90. Novartis International Company Details
Table 91. Novartis International Business Overview
Table 92. Novartis International Cancer Biological Therapy Product
Table 93. Novartis International Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 94. Novartis International Recent Developments
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Cancer Biological Therapy Product
Table 98. Pfizer Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 99. Pfizer Recent Developments
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Cancer Biological Therapy Product
Table 103. Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 104. Bristol-Myers Squibb Recent Developments
Table 105. Seattle Genetics Company Details
Table 106. Seattle Genetics Business Overview
Table 107. Seattle Genetics Cancer Biological Therapy Product
Table 108. Seattle Genetics Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 109. Seattle Genetics Recent Developments
Table 110. Amgen Company Details
Table 111. Amgen Business Overview
Table 112. Amgen Cancer Biological Therapy Product
Table 113. Amgen Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 114. Amgen Recent Developments
Table 115. Takeda Pharmaceuticals Company Details
Table 116. Takeda Pharmaceuticals Business Overview
Table 117. Takeda Pharmaceuticals Cancer Biological Therapy Product
Table 118. Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 119. Takeda Pharmaceuticals Recent Developments
Table 120. GlaxoSmithKline Company Details
Table 121. GlaxoSmithKline Business Overview
Table 122. GlaxoSmithKline Cancer Biological Therapy Product
Table 123. GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 124. GlaxoSmithKline Recent Developments
Table 125. Spectrum Pharmaceuticals Company Details
Table 126. Spectrum Pharmaceuticals Business Overview
Table 127. Spectrum Pharmaceuticals Cancer Biological Therapy Product
Table 128. Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 129. Spectrum Pharmaceuticals Recent Developments
Table 130. Celgene Corporation Company Details
Table 131. Celgene Corporation Business Overview
Table 132. Celgene Corporation Cancer Biological Therapy Product
Table 133. Celgene Corporation Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 134. Celgene Corporation Recent Developments
Table 135. AstraZeneca, Plc. Company Details
Table 136. AstraZeneca, Plc. Business Overview
Table 137. AstraZeneca, Plc. Cancer Biological Therapy Product
Table 138. AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 139. AstraZeneca, Plc. Recent Developments
Table 140. Otsuka Company Details
Table 141. Otsuka Business Overview
Table 142. Otsuka Cancer Biological Therapy Product
Table 143. Otsuka Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 144. Otsuka Recent Developments
Table 145. Eisai Company Details
Table 146. Eisai Business Overview
Table 147. Eisai Cancer Biological Therapy Product
Table 148. Eisai Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 149. Eisai Recent Developments
Table 150. Abbvie Company Details
Table 151. Abbvie Business Overview
Table 152. Abbvie Cancer Biological Therapy Product
Table 153. Abbvie Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 154. Abbvie Recent Developments
Table 155. Incyte Company Details
Table 156. Incyte Business Overview
Table 157. Incyte Cancer Biological Therapy Product
Table 158. Incyte Revenue in Cancer Biological Therapy Business (2018-2023) & (US$ Million)
Table 159. Incyte Recent Developments
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biological Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cancer Biological Therapy Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Antibodies Features
Figure 4. Vaccines Features
Figure 5. Cancer Growth Blockers Features
Figure 6. Blood Cell Growth Factors Features
Figure 7. Global Cancer Biological Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Cancer Biological Therapy Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Research & Academic Laboratories Case Studies
Figure 12. Pharmaceutical & Biotechnology Companies Case Studies
Figure 13. Cancer Biological Therapy Report Years Considered
Figure 14. Global Cancer Biological Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Cancer Biological Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Cancer Biological Therapy Market Share by Region: 2022 VS 2033
Figure 17. Global Cancer Biological Therapy Market Share by Players in 2022
Figure 18. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Biological Therapy Revenue in 2022
Figure 20. North America Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Cancer Biological Therapy Market Share by Type (2018-2033)
Figure 22. North America Cancer Biological Therapy Market Share by Application (2018-2033)
Figure 23. North America Cancer Biological Therapy Market Share by Country (2018-2033)
Figure 24. United States Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Cancer Biological Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Cancer Biological Therapy Market Share by Type (2018-2033)
Figure 28. Europe Cancer Biological Therapy Market Share by Application (2018-2033)
Figure 29. Europe Cancer Biological Therapy Market Share by Country (2018-2033)
Figure 30. Germany Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Cancer Biological Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Cancer Biological Therapy Market Share by Type (2018-2033)
Figure 38. China Cancer Biological Therapy Market Share by Application (2018-2033)
Figure 39. Asia Cancer Biological Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Cancer Biological Therapy Market Share by Type (2018-2033)
Figure 41. Asia Cancer Biological Therapy Market Share by Application (2018-2033)
Figure 42. Asia Cancer Biological Therapy Market Share by Region (2018-2033)
Figure 43. Japan Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Cancer Biological Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Cancer Biological Therapy Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Cancer Biological Therapy Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Cancer Biological Therapy Market Share by Country (2018-2033)
Figure 53. Brazil Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Cancer Biological Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 60. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 61. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 62. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 63. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 64. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 65. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 67. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 68. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 69. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 71. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 72. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 73. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 74. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 75. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 76. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 77. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed